Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts

Fig. 2

Efficacy of i.p. CpG-ODN1826 (20 µg/mouse, qdx5d/wx4w) against orthotopic DMPM MesoII xenografts. a Kaplan–Meier plot of the percentage of ascites-free mice over time since i.p. MesoII cell injection. Mice (six animals/group) were randomized to receive saline (Δ) or CpG-ODN1826 (▲). The treatment started 4 days after cell inoculum (early-stage tumors). b Body weight variations in the two experimental groups reported in panel (a)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us